<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Phys.org: Phys.Org news tagged with: melanoma</title>
<link>http://phys.org/</link>
<language>en-us</language> 
<description>Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Novel microscope could be used for melanoma detection</title>
   	 <description>Suspicion of melanoma: In the future, doctors can pull out a new type of microscope to get to the bottom of suspicious changes in the skin. It provides a high-resolution image of skin areas of any size &amp;#150; and so quickly that you can hold it in your hand without blurring the resulting picture.</description>
     <link>http://phys.org/news224261870.html</link>
	 <category>Technology</category>
	 <pubDate>Tue, 10 May 2011 15:58:04 EST</pubDate>
	 <guid isPermaLink="false">news224261870</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2011/microscopeha.jpg" width="90" height="90" />
</item>
<item>
     <title>Nationwide study examines youth access to indoor tanning</title>
   	 <description>Many indoor tanning businesses require parental consent for teenagers to use their facilities, but most would allow young tanners more than the government-recommended amount of exposure during the first week, according to a report in the September issue of Archives of Dermatology. Facilities with specific state laws regarding parental consent or accompaniment were more likely to require these steps.</description>
     <link>http://phys.org/news172770238.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 21 Sep 2009 17:00:02 EST</pubDate>
	 <guid isPermaLink="false">news172770238</guid>
	 
</item>
<item>
     <title>Study reveals new genetic culprit in deadly skin cancer</title>
   	 <description>Drawing on the power of  DNA sequencing, National Institutes of Health researchers have identified a new group of genetic mutations involved in the deadliest form of skin cancer, melanoma. This discovery is particularly encouraging because some of the mutations, which were found in nearly one-fifth of melanoma cases, reside in a gene already targeted by a drug approved for certain types of breast cancer.</description>
     <link>http://phys.org/news170945921.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 31 Aug 2009 13:59:07 EST</pubDate>
	 <guid isPermaLink="false">news170945921</guid>
	 
</item>
<item>
     <title>Melanosome dynamics and sensitivity of melanoma cells to chemotherapy</title>
   	 <description>Manipulating the functions of melanosomes--the organelles in pigment-producing cells--may enhance the activity of anticancer drugs used against melanoma, according to a new study published online August 24 in the Journal of the National Cancer Institute.</description>
     <link>http://phys.org/news170351264.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 25 Aug 2009 02:50:01 EST</pubDate>
	 <guid isPermaLink="false">news170351264</guid>
	 
</item>
<item>
     <title>Dermatologist skin examinations detect more, thinner skin cancers than patients identify themselves</title>
   	 <description>Most melanomas detected in a general-practice dermatology clinic were found by dermatologists during full-body skin examinations of patients who had come to the clinic for different complaints, according to a report in the August issue of Archives of Dermatology. In addition, cancers detected by dermatologists were thinner and more likely to be in situ (only on the outer layer of skin) than were cancers detected by patients.</description>
     <link>http://phys.org/news169750632.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 17 Aug 2009 18:10:01 EST</pubDate>
	 <guid isPermaLink="false">news169750632</guid>
	 
</item>
<item>
     <title>Antioxidants not associated with increased melanoma risk</title>
   	 <description>Antioxidant supplements do not appear to be associated with an increased risk of melanoma, according to a report in the August issue of Archives of Dermatology.</description>
     <link>http://phys.org/news169749557.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 17 Aug 2009 17:40:02 EST</pubDate>
	 <guid isPermaLink="false">news169749557</guid>
	 
</item>
<item>
     <title>Budesonide is not beneficial for the treatment of diarrhea in metastatic melanoma patients</title>
   	 <description>Patients with stage III or IV melanoma taking ipilimumab and the oral steroid budesonide to reduce side effects did not have less diarrhea, a known side effect of ipilimumab, according to results of a phase II trial published in Clinical Cancer Research, a journal of the American Association for Cancer Research.</description>
     <link>http://phys.org/news169229472.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 11 Aug 2009 17:40:06 EST</pubDate>
	 <guid isPermaLink="false">news169229472</guid>
	 
</item>
<item>
     <title>Study identifies risk factors for transformation of eye growths into melanoma</title>
   	 <description>Eight factors may predict whether a choroidal nevus -- a benign, flat, pigmented growth inside the eye and beneath the retina -- may develop into melanoma, according to a report in the August issue of Archives of Ophthalmology.</description>
     <link>http://phys.org/news169141385.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 10 Aug 2009 17:00:02 EST</pubDate>
	 <guid isPermaLink="false">news169141385</guid>
	 
</item>
<item>
     <title>Researchers launch study into search-and-destroy antigen for deadly skin cancer</title>
   	 <description>UT Southwestern Medical Center researchers are studying a new antigen to see whether it can track down and kill cancer cells in patients with recurring melanoma, the leading cause of skin cancer deaths.</description>
     <link>http://phys.org/news169124584.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 10 Aug 2009 12:03:28 EST</pubDate>
	 <guid isPermaLink="false">news169124584</guid>
	 
</item>
<item>
     <title>Sensitizing tumor response to cancer therapy</title>
   	 <description>Two forms of skin and brain cancer respond very poorly to chemotherapy and radiation: melanoma and glioblastoma multiforme brain cancer.</description>
     <link>http://phys.org/news168706119.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 05 Aug 2009 16:10:02 EST</pubDate>
	 <guid isPermaLink="false">news168706119</guid>
	 
</item>
<item>
     <title>Researchers identify new method to selectively kill metastatic melanoma cells</title>
   	 <description>(PhysOrg.com) -- An international team of researchers has identified a new method for selectively killing metastatic melanoma cells, which may lead to new areas for drug development in melanoma - a cancer that is highly resistant to current treatment strategies.</description>
     <link>http://phys.org/news168523956.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 03 Aug 2009 13:40:03 EST</pubDate>
	 <guid isPermaLink="false">news168523956</guid>
	 
</item>
<item>
     <title>Viral mimic induces melanoma cells to digest themselves</title>
   	 <description>Recent research has uncovered an unexpected vulnerability in deadly melanoma cells that, when exploited, can cause the cancer cells to turn against themselves. The study, published by Cell Press in the August issue of the journal Cancer Cell, identifies a new target for development of future therapeutics aimed at selectively eliminating this aggressive skin cancer which is characterized by a notoriously high rate of metastasis and treatment-resistance.</description>
     <link>http://phys.org/news168523563.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 03 Aug 2009 13:06:23 EST</pubDate>
	 <guid isPermaLink="false">news168523563</guid>
	 
</item>
<item>
     <title>Antibody targeting of glioblastoma shows promise in preclinical tests</title>
   	 <description>Cancer researchers at Georgetown University's Lombardi Comprehensive Cancer Center have successfully tested a small, engineered antibody they say shuts down growth of human glioblastoma tumors in cell and animal studies. Glioblastoma is the deadliest of brain cancers; there is no effective treatment.</description>
     <link>http://phys.org/news168253487.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 31 Jul 2009 10:05:36 EST</pubDate>
	 <guid isPermaLink="false">news168253487</guid>
	 
</item>
<item>
     <title>Study shows cancer vaccines led to long-term survival for patients with metastatic melanoma</title>
   	 <description>Hoag Memorial Hospital Presbyterian today announced promising data from a clinical study showing patient-specific cancer vaccines derived from patients' own cancer cells and immune cells were well tolerated and resulted in impressive long-term survival rates in patients with metastatic melanoma whose disease had been minimized by other therapies.</description>
     <link>http://phys.org/news168017006.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 28 Jul 2009 16:23:50 EST</pubDate>
	 <guid isPermaLink="false">news168017006</guid>
	 
</item>
<item>
     <title>Researchers identify genes that cause melanoma</title>
   	 <description>Scientists from the Queensland Institute of Medical Research (QIMR) have found two new genes that together double a person's risk of developing melanoma.</description>
     <link>http://phys.org/news166098212.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 06 Jul 2009 11:23:56 EST</pubDate>
	 <guid isPermaLink="false">news166098212</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/molesholdthe.jpg" width="90" height="92" />
</item>
<item>
     <title>Researchers testing virus-gene therapy combination against melanoma</title>
   	 <description>Researchers at the Moores UCSD Cancer Center are injecting a modified herpes virus into melanoma tumors, hoping to kill the cancer cells while also bolstering the body's immune defenses against the disease.</description>
     <link>http://phys.org/news165687558.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 01 Jul 2009 17:20:27 EST</pubDate>
	 <guid isPermaLink="false">news165687558</guid>
	 
</item>
<item>
     <title>Hunt for Blood Test to Determine Melanoma Survival Rates</title>
   	 <description>(PhysOrg.com) -- Research at the University of Leicester will be breaking new ground in the search for a simple blood test that could tell whether a patient with melanoma has the condition in an aggressive form.</description>
     <link>http://phys.org/news165567405.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 30 Jun 2009 07:57:16 EST</pubDate>
	 <guid isPermaLink="false">news165567405</guid>
	 
</item>
<item>
     <title>Novel epigenetic markers of melanoma may herald new treatments for patients</title>
   	 <description>Melanoma is the most serious form of skin cancer, diagnosed in more than 50,000 new patients in the United States annually.  While the rate of incidences continues to rise, survival rate has not improved and the race is on to find the genetic and cellular changes driving melanoma and to devise new means of detection and treatment.  In a study published online in Genome Research, scientists have mapped chemical modifications of DNA in the melanoma genome, finding new markers that will help develop more effective treatment strategies to fight this disease.</description>
     <link>http://phys.org/news165509319.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 29 Jun 2009 15:49:20 EST</pubDate>
	 <guid isPermaLink="false">news165509319</guid>
	 
</item>
<item>
     <title>Australian coastal and river dwellers at risk of melanoma</title>
   	 <description>(PhysOrg.com) -- South Australians living on the coast, near the River Murray and in metropolitan Adelaide are more likely to get skin cancer than their inland cousins.</description>
     <link>http://phys.org/news165160647.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 25 Jun 2009 14:58:08 EST</pubDate>
	 <guid isPermaLink="false">news165160647</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/coastalandri.jpg" width="90" height="67" />
</item>
<item>
     <title>Germany bans solariums for under-18s</title>
   	 <description> The German lower house of parliament on Friday passed a law banning under-18s from going to solariums because of the risks of developing skin cancer.</description>
     <link>http://phys.org/news164627121.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 19 Jun 2009 10:45:42 EST</pubDate>
	 <guid isPermaLink="false">news164627121</guid>
	 
</item>
<item>
     <title>Vaccine shows therapeutic promise against advanced melanoma</title>
   	 <description>A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, according to researchers from The University of Texas M. D. Anderson Cancer Center.</description>
     <link>http://phys.org/news163071438.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 01 Jun 2009 10:39:48 EST</pubDate>
	 <guid isPermaLink="false">news163071438</guid>
	 
</item>
<item>
     <title>The Medical Minute: Melanoma - The dark side of the sun</title>
   	 <description>Now that the weather is nice, people will spend more time outside. Whether it’s doing yard work, playing golf or relaxing at the beach, we are a nation of sun lovers. Some people with light skin may even spend a few sessions in the tanning booth to begin to develop a golden hue that looks like they spent a week at the beach. Others work outside and whether they planned to or not, they will get more sunlight for the next six months. This carries a note of concern, since sunlight is very likely the reason malignant melanoma incidence has doubled since the 1970’s with an estimated 69,000 new cases expected this year and almost 9,000 deaths.</description>
     <link>http://phys.org/news162666086.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 27 May 2009 18:02:26 EST</pubDate>
	 <guid isPermaLink="false">news162666086</guid>
	 
</item>
<item>
     <title>Zebrafish provide a model for cancerous melanoma in humans</title>
   	 <description>In a new study published in Disease Models &amp; Mechanisms, scientists use the zebrafish to gain insight into the influence of known cancer genes on the development and progression of melanoma, an aggressive form of human skin cancer with limited treatment options.</description>
     <link>http://phys.org/news162541686.html</link>
	 <category>Biology</category>
	 <pubDate>Tue, 26 May 2009 07:28:20 EST</pubDate>
	 <guid isPermaLink="false">news162541686</guid>
	 
</item>
<item>
     <title>Topical cream studied as way to treat skin cancer without the knife</title>
   	 <description>In a case study of a type of melanoma skin cancer typically found on chronically sun-exposed skin, Saint Louis University researchers found that imiquimod, a topical cream, produced good results for patients when used together with surgery to treat the cancer, potentially helping doctors cut less.</description>
     <link>http://phys.org/news160165364.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 28 Apr 2009 19:23:32 EST</pubDate>
	 <guid isPermaLink="false">news160165364</guid>
	 
</item>
<item>
     <title>Study finds photographs of UV exposure can impact sunburns in preteens</title>
   	 <description>Researchers from Boston University School of Medicine (BUSM) have found that among preteens, the use of photographs to measure ultraviolet (UV) exposure, could motivate them to improve sun protection practices and limit number of sunburns. These findings appear in the April 2009 issue of the Journal of the Dermatology Nurses' Association.</description>
     <link>http://phys.org/news159685661.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 23 Apr 2009 06:08:16 EST</pubDate>
	 <guid isPermaLink="false">news159685661</guid>
	 
</item>
<item>
     <title>Dark hair? Don't burn? Your genes may still put you at risk for melanoma</title>
   	 <description>New genetic research suggests that the traditional risk factors for melanoma may not be as helpful in predicting risk in all people as previously thought, according to data presented at the American Association for Cancer Research 100th Annual Meeting 2009.</description>
     <link>http://phys.org/news159559395.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 21 Apr 2009 19:04:16 EST</pubDate>
	 <guid isPermaLink="false">news159559395</guid>
	 
</item>
<item>
     <title>Survey identifies factors associated with early detection of melanoma in older men</title>
   	 <description>Older men whose melanoma is detected by a physician are more likely to have thinner and therefore more treatable tumors at diagnosis, according to results of a survey published in the April issue of Archives of Dermatology, one of the JAMA/Archives journals. A second analysis of the same survey data finds that physician detection of thin melanoma is more common in those who are 65 or older, have cancers on their backs or who have a history of atypical moles.</description>
     <link>http://phys.org/news159464945.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 20 Apr 2009 16:49:17 EST</pubDate>
	 <guid isPermaLink="false">news159464945</guid>
	 
</item>
<item>
     <title>New therapeutic target for melanoma identified</title>
   	 <description>A protein called Mcl-1 plays a critical role in melanoma cell resistance to a form of apoptosis called anoikis, according to research published this week in Molecular Cancer Research.</description>
     <link>http://phys.org/news159081716.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 16 Apr 2009 06:22:39 EST</pubDate>
	 <guid isPermaLink="false">news159081716</guid>
	 
</item>
<item>
     <title>Researchers reveal how immune cells can be harnessed to target melanoma</title>
   	 <description>Researchers at the Babraham Institute and the University of Catanzaro &quot;Magna Graecia&quot;, Italy, co-ordinating an international network of scientists and clinicians from Europe, the USA and Japan, have identified new mechanisms through which the immune system recognises and responds to tumours like melanomas. This discovery may offer therapeutic approaches for tackling metastatic melanoma, an aggressive form of skin cancer responsible for around 2,000 deaths in the UK each year.</description>
     <link>http://phys.org/news158570124.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 10 Apr 2009 08:15:58 EST</pubDate>
	 <guid isPermaLink="false">news158570124</guid>
	 
</item>
<item>
     <title>New method for detection of phosphoproteins reveals regulator of melanoma invasion</title>
   	 <description>Scientists have developed a new approach for surveying phosphorylation, a process that is regulated by critical cell signaling pathways and regulates several key cellular signaling events. The research, published by Cell Press in the April 10th issue of the journal Molecular Cell, describes the regulation of a previously uncharacterized protein and demonstrates that it plays an important role in cancer cell invasion.</description>
     <link>http://phys.org/news158502443.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 09 Apr 2009 13:27:55 EST</pubDate>
	 <guid isPermaLink="false">news158502443</guid>
	 
</item>


</channel>
</rss>
